Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.

NCT00790192 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

488

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Lurasidone
DRUG: Lurasidone
DRUG: Quetiapine XR
DRUG: Placebo

Sponsor

Sumitomo Pharma America, Inc.